How we help data migration for the medical industry? Read the full story about the migration
Ipsen is a French pharmaceutical company headquartered in Paris, France. With more than 1,2 billion in revenue, 4600 employees worldwide, and drugs marketed in 115 countries, Ipsen is among the top ten pharmaceutical companies in the world. Dedicated to improving lives through innovative medicines in Oncology, Neuroscience, and Rare Diseases, they also have a well-established and successful Consumer Healthcare business. Ipsen group is committed to discovering new solutions for targeting debilitating diseases and improving the quality of life for patients.
Ipsen’s commitment to R&D is our bold promise to launch at least one new drug or meaningful new indication every year. Our end goal is to ensure that we bring innovative medicines to market to address unmet patient needs as quickly as possible.
Today, Ipsen Group’s medicines are used in over 115 countries across the globe.
The migration scenario was from GSuite to O365. The first difficulty was moving 5800 users and 17 TB of data in a seamless way and with no impact on day to day business. The requirement for a tool able to synchronize data from the source and target tenant with no business downtime was essential. Some other features were also mandatory to ensure success:
VNext is an innovating Startup focusing on new technologies, new usages, and new distribution modes such as SaaS, PaaS, and Cloud. Visit www.vnext-group.com
Migration has been a non-event for Ipsen employees, which was saluted by the governance. The GSuite to O365 transition was seamless and with complete availability of the messaging system and without any disruption for Ipsen users. The migration tools worked just as expected, and we are now enjoying our Office 365 environment…
Mickaël Corniaux, head of IT IPSEN